nodes	percent_of_prediction	percent_of_DWPC	metapath
Brinzolamide—CA9—breast cancer	0.362	0.776	CbGaD
Brinzolamide—CYP3A4—breast cancer	0.104	0.224	CbGaD
Brinzolamide—CYP3A4—Exemestane—breast cancer	0.0296	0.133	CbGbCtD
Brinzolamide—CYP3A4—Letrozole—breast cancer	0.0252	0.113	CbGbCtD
Brinzolamide—CYP3A4—Anastrozole—breast cancer	0.0224	0.101	CbGbCtD
Brinzolamide—CYP3A4—Toremifene—breast cancer	0.0205	0.0921	CbGbCtD
Brinzolamide—CYP3A4—Fulvestrant—breast cancer	0.0191	0.0856	CbGbCtD
Brinzolamide—CYP3A4—Thiotepa—breast cancer	0.017	0.0763	CbGbCtD
Brinzolamide—CYP3A4—Ixabepilone—breast cancer	0.0155	0.0698	CbGbCtD
Brinzolamide—CYP3A4—Lapatinib—breast cancer	0.015	0.0672	CbGbCtD
Brinzolamide—CYP3A4—Raloxifene—breast cancer	0.0113	0.0509	CbGbCtD
Brinzolamide—CYP3A4—Vinorelbine—breast cancer	0.0083	0.0373	CbGbCtD
Brinzolamide—CYP3A4—Tamoxifen—breast cancer	0.00749	0.0336	CbGbCtD
Brinzolamide—CYP3A4—Mitoxantrone—breast cancer	0.00731	0.0328	CbGbCtD
Brinzolamide—CYP3A4—Paclitaxel—breast cancer	0.00583	0.0262	CbGbCtD
Brinzolamide—CYP3A4—Irinotecan—breast cancer	0.00575	0.0258	CbGbCtD
Brinzolamide—CYP3A4—Vinblastine—breast cancer	0.00512	0.023	CbGbCtD
Brinzolamide—CYP3A4—Docetaxel—breast cancer	0.00422	0.0189	CbGbCtD
Brinzolamide—CYP3A4—Doxorubicin—breast cancer	0.00314	0.0141	CbGbCtD
Brinzolamide—Dorzolamide—CA9—breast cancer	0.00304	0.776	CrCbGaD
Brinzolamide—CA5A—female reproductive system—breast cancer	0.0015	0.0699	CbGeAlD
Brinzolamide—CA5B—mammary gland—breast cancer	0.00141	0.0655	CbGeAlD
Brinzolamide—CA5A—endocrine gland—breast cancer	0.00127	0.0592	CbGeAlD
Brinzolamide—CA9—female reproductive system—breast cancer	0.000878	0.0408	CbGeAlD
Brinzolamide—Dorzolamide—CYP3A4—breast cancer	0.000875	0.224	CrCbGaD
Brinzolamide—CA14—adrenal gland—breast cancer	0.000813	0.0378	CbGeAlD
Brinzolamide—CA4—nipple—breast cancer	0.000804	0.0374	CbGeAlD
Brinzolamide—CA9—endocrine gland—breast cancer	0.000743	0.0346	CbGeAlD
Brinzolamide—CA2—nipple—breast cancer	0.000667	0.031	CbGeAlD
Brinzolamide—CA12—female reproductive system—breast cancer	0.00065	0.0302	CbGeAlD
Brinzolamide—CA5B—adipose tissue—breast cancer	0.000634	0.0295	CbGeAlD
Brinzolamide—CA5B—female reproductive system—breast cancer	0.000583	0.0271	CbGeAlD
Brinzolamide—CA5B—adrenal gland—breast cancer	0.000569	0.0264	CbGeAlD
Brinzolamide—CA1—adipose tissue—breast cancer	0.00056	0.026	CbGeAlD
Brinzolamide—CA2—embryo—breast cancer	0.00055	0.0256	CbGeAlD
Brinzolamide—CA12—endocrine gland—breast cancer	0.00055	0.0256	CbGeAlD
Brinzolamide—CA1—female reproductive system—breast cancer	0.000515	0.0239	CbGeAlD
Brinzolamide—CA5B—endocrine gland—breast cancer	0.000493	0.0229	CbGeAlD
Brinzolamide—CA1—bone marrow—breast cancer	0.000486	0.0226	CbGeAlD
Brinzolamide—CA2—epithelium—breast cancer	0.000449	0.0209	CbGeAlD
Brinzolamide—CA4—pituitary gland—breast cancer	0.000439	0.0204	CbGeAlD
Brinzolamide—CA4—adipose tissue—breast cancer	0.000438	0.0203	CbGeAlD
Brinzolamide—CA1—endocrine gland—breast cancer	0.000436	0.0203	CbGeAlD
Brinzolamide—CA2—skin of body—breast cancer	0.000427	0.0199	CbGeAlD
Brinzolamide—CA4—female reproductive system—breast cancer	0.000402	0.0187	CbGeAlD
Brinzolamide—CA4—adrenal gland—breast cancer	0.000393	0.0183	CbGeAlD
Brinzolamide—CA4—bone marrow—breast cancer	0.00038	0.0177	CbGeAlD
Brinzolamide—CA4—female gonad—breast cancer	0.000366	0.017	CbGeAlD
Brinzolamide—CA2—pituitary gland—breast cancer	0.000364	0.0169	CbGeAlD
Brinzolamide—CA2—adipose tissue—breast cancer	0.000363	0.0169	CbGeAlD
Brinzolamide—CA5B—lymph node—breast cancer	0.000341	0.0159	CbGeAlD
Brinzolamide—CA4—endocrine gland—breast cancer	0.00034	0.0158	CbGeAlD
Brinzolamide—CA2—female reproductive system—breast cancer	0.000334	0.0155	CbGeAlD
Brinzolamide—CA2—adrenal gland—breast cancer	0.000326	0.0151	CbGeAlD
Brinzolamide—CA2—bone marrow—breast cancer	0.000315	0.0146	CbGeAlD
Brinzolamide—CA2—female gonad—breast cancer	0.000304	0.0141	CbGeAlD
Brinzolamide—CA1—lymph node—breast cancer	0.000301	0.014	CbGeAlD
Brinzolamide—CA2—endocrine gland—breast cancer	0.000282	0.0131	CbGeAlD
Brinzolamide—CA4—lymph node—breast cancer	0.000235	0.0109	CbGeAlD
Brinzolamide—CYP3A4—female reproductive system—breast cancer	0.000215	0.01	CbGeAlD
Brinzolamide—CA2—lymph node—breast cancer	0.000195	0.00907	CbGeAlD
Brinzolamide—CYP3A4—endocrine gland—breast cancer	0.000182	0.00847	CbGeAlD
Brinzolamide—Connective tissue disorder—Epirubicin—breast cancer	5.29e-05	0.000257	CcSEcCtD
Brinzolamide—Urethral disorder—Epirubicin—breast cancer	5.28e-05	0.000256	CcSEcCtD
Brinzolamide—Hepatobiliary disease—Doxorubicin—breast cancer	5.25e-05	0.000255	CcSEcCtD
Brinzolamide—Epistaxis—Doxorubicin—breast cancer	5.23e-05	0.000254	CcSEcCtD
Brinzolamide—Angiopathy—Methotrexate—breast cancer	5.22e-05	0.000253	CcSEcCtD
Brinzolamide—Vomiting—Mitoxantrone—breast cancer	5.21e-05	0.000253	CcSEcCtD
Brinzolamide—Vomiting—Irinotecan—breast cancer	5.21e-05	0.000253	CcSEcCtD
Brinzolamide—Sinusitis—Doxorubicin—breast cancer	5.2e-05	0.000253	CcSEcCtD
Brinzolamide—Immune system disorder—Methotrexate—breast cancer	5.19e-05	0.000252	CcSEcCtD
Brinzolamide—Dizziness—Fluorouracil—breast cancer	5.19e-05	0.000252	CcSEcCtD
Brinzolamide—Visual impairment—Epirubicin—breast cancer	5.19e-05	0.000252	CcSEcCtD
Brinzolamide—Mediastinal disorder—Methotrexate—breast cancer	5.18e-05	0.000252	CcSEcCtD
Brinzolamide—Rash—Mitoxantrone—breast cancer	5.17e-05	0.000251	CcSEcCtD
Brinzolamide—Rash—Irinotecan—breast cancer	5.17e-05	0.000251	CcSEcCtD
Brinzolamide—Dermatitis—Mitoxantrone—breast cancer	5.17e-05	0.000251	CcSEcCtD
Brinzolamide—Dermatitis—Irinotecan—breast cancer	5.17e-05	0.000251	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Docetaxel—breast cancer	5.16e-05	0.000251	CcSEcCtD
Brinzolamide—Headache—Mitoxantrone—breast cancer	5.14e-05	0.00025	CcSEcCtD
Brinzolamide—Headache—Irinotecan—breast cancer	5.14e-05	0.00025	CcSEcCtD
Brinzolamide—Hypotension—Capecitabine—breast cancer	5.13e-05	0.000249	CcSEcCtD
Brinzolamide—Insomnia—Docetaxel—breast cancer	5.13e-05	0.000249	CcSEcCtD
Brinzolamide—Paraesthesia—Docetaxel—breast cancer	5.09e-05	0.000247	CcSEcCtD
Brinzolamide—Alopecia—Methotrexate—breast cancer	5.08e-05	0.000247	CcSEcCtD
Brinzolamide—Vomiting—Gemcitabine—breast cancer	5.08e-05	0.000247	CcSEcCtD
Brinzolamide—Bradycardia—Doxorubicin—breast cancer	5.07e-05	0.000246	CcSEcCtD
Brinzolamide—Dyspnoea—Docetaxel—breast cancer	5.05e-05	0.000245	CcSEcCtD
Brinzolamide—Somnolence—Docetaxel—breast cancer	5.04e-05	0.000245	CcSEcCtD
Brinzolamide—Mental disorder—Methotrexate—breast cancer	5.04e-05	0.000245	CcSEcCtD
Brinzolamide—Rash—Gemcitabine—breast cancer	5.04e-05	0.000245	CcSEcCtD
Brinzolamide—Dermatitis—Gemcitabine—breast cancer	5.03e-05	0.000244	CcSEcCtD
Brinzolamide—Eye disorder—Epirubicin—breast cancer	5.03e-05	0.000244	CcSEcCtD
Brinzolamide—Tinnitus—Epirubicin—breast cancer	5.02e-05	0.000244	CcSEcCtD
Brinzolamide—Erythema—Methotrexate—breast cancer	5.01e-05	0.000243	CcSEcCtD
Brinzolamide—Malnutrition—Methotrexate—breast cancer	5.01e-05	0.000243	CcSEcCtD
Brinzolamide—Headache—Gemcitabine—breast cancer	5e-05	0.000243	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Capecitabine—breast cancer	5e-05	0.000243	CcSEcCtD
Brinzolamide—Cardiac disorder—Epirubicin—breast cancer	4.99e-05	0.000243	CcSEcCtD
Brinzolamide—Vomiting—Fluorouracil—breast cancer	4.99e-05	0.000243	CcSEcCtD
Brinzolamide—Rhinitis—Doxorubicin—breast cancer	4.99e-05	0.000243	CcSEcCtD
Brinzolamide—Dyspepsia—Docetaxel—breast cancer	4.99e-05	0.000242	CcSEcCtD
Brinzolamide—Insomnia—Capecitabine—breast cancer	4.96e-05	0.000241	CcSEcCtD
Brinzolamide—Hypoaesthesia—Doxorubicin—breast cancer	4.95e-05	0.000241	CcSEcCtD
Brinzolamide—Rash—Fluorouracil—breast cancer	4.95e-05	0.000241	CcSEcCtD
Brinzolamide—Dermatitis—Fluorouracil—breast cancer	4.95e-05	0.00024	CcSEcCtD
Brinzolamide—Pharyngitis—Doxorubicin—breast cancer	4.94e-05	0.00024	CcSEcCtD
Brinzolamide—Paraesthesia—Capecitabine—breast cancer	4.93e-05	0.000239	CcSEcCtD
Brinzolamide—Decreased appetite—Docetaxel—breast cancer	4.93e-05	0.000239	CcSEcCtD
Brinzolamide—Hypersensitivity—Paclitaxel—breast cancer	4.93e-05	0.000239	CcSEcCtD
Brinzolamide—Headache—Fluorouracil—breast cancer	4.92e-05	0.000239	CcSEcCtD
Brinzolamide—Urinary tract disorder—Doxorubicin—breast cancer	4.92e-05	0.000239	CcSEcCtD
Brinzolamide—Oedema peripheral—Doxorubicin—breast cancer	4.91e-05	0.000238	CcSEcCtD
Brinzolamide—Dysgeusia—Methotrexate—breast cancer	4.9e-05	0.000238	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Docetaxel—breast cancer	4.89e-05	0.000238	CcSEcCtD
Brinzolamide—Connective tissue disorder—Doxorubicin—breast cancer	4.89e-05	0.000238	CcSEcCtD
Brinzolamide—Dyspnoea—Capecitabine—breast cancer	4.89e-05	0.000238	CcSEcCtD
Brinzolamide—Fatigue—Docetaxel—breast cancer	4.89e-05	0.000237	CcSEcCtD
Brinzolamide—Angiopathy—Epirubicin—breast cancer	4.88e-05	0.000237	CcSEcCtD
Brinzolamide—Urethral disorder—Doxorubicin—breast cancer	4.88e-05	0.000237	CcSEcCtD
Brinzolamide—Nausea—Irinotecan—breast cancer	4.87e-05	0.000237	CcSEcCtD
Brinzolamide—Nausea—Mitoxantrone—breast cancer	4.87e-05	0.000237	CcSEcCtD
Brinzolamide—Immune system disorder—Epirubicin—breast cancer	4.86e-05	0.000236	CcSEcCtD
Brinzolamide—Mediastinal disorder—Epirubicin—breast cancer	4.85e-05	0.000236	CcSEcCtD
Brinzolamide—Pain—Docetaxel—breast cancer	4.85e-05	0.000235	CcSEcCtD
Brinzolamide—Back pain—Methotrexate—breast cancer	4.84e-05	0.000235	CcSEcCtD
Brinzolamide—Dyspepsia—Capecitabine—breast cancer	4.83e-05	0.000235	CcSEcCtD
Brinzolamide—Arrhythmia—Epirubicin—breast cancer	4.81e-05	0.000234	CcSEcCtD
Brinzolamide—Visual impairment—Doxorubicin—breast cancer	4.8e-05	0.000233	CcSEcCtD
Brinzolamide—Asthenia—Paclitaxel—breast cancer	4.8e-05	0.000233	CcSEcCtD
Brinzolamide—Decreased appetite—Capecitabine—breast cancer	4.77e-05	0.000232	CcSEcCtD
Brinzolamide—Alopecia—Epirubicin—breast cancer	4.76e-05	0.000231	CcSEcCtD
Brinzolamide—Nausea—Gemcitabine—breast cancer	4.74e-05	0.00023	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Capecitabine—breast cancer	4.74e-05	0.00023	CcSEcCtD
Brinzolamide—Fatigue—Capecitabine—breast cancer	4.73e-05	0.00023	CcSEcCtD
Brinzolamide—Pruritus—Paclitaxel—breast cancer	4.73e-05	0.00023	CcSEcCtD
Brinzolamide—Vision blurred—Methotrexate—breast cancer	4.72e-05	0.000229	CcSEcCtD
Brinzolamide—Mental disorder—Epirubicin—breast cancer	4.72e-05	0.000229	CcSEcCtD
Brinzolamide—Pain—Capecitabine—breast cancer	4.69e-05	0.000228	CcSEcCtD
Brinzolamide—Erythema—Epirubicin—breast cancer	4.69e-05	0.000228	CcSEcCtD
Brinzolamide—Malnutrition—Epirubicin—breast cancer	4.69e-05	0.000228	CcSEcCtD
Brinzolamide—Feeling abnormal—Docetaxel—breast cancer	4.67e-05	0.000227	CcSEcCtD
Brinzolamide—Nausea—Fluorouracil—breast cancer	4.67e-05	0.000227	CcSEcCtD
Brinzolamide—Eye disorder—Doxorubicin—breast cancer	4.65e-05	0.000226	CcSEcCtD
Brinzolamide—Ill-defined disorder—Methotrexate—breast cancer	4.65e-05	0.000226	CcSEcCtD
Brinzolamide—Tinnitus—Doxorubicin—breast cancer	4.64e-05	0.000226	CcSEcCtD
Brinzolamide—Cardiac disorder—Doxorubicin—breast cancer	4.62e-05	0.000224	CcSEcCtD
Brinzolamide—Flatulence—Epirubicin—breast cancer	4.62e-05	0.000224	CcSEcCtD
Brinzolamide—Tension—Epirubicin—breast cancer	4.6e-05	0.000223	CcSEcCtD
Brinzolamide—Dysgeusia—Epirubicin—breast cancer	4.59e-05	0.000223	CcSEcCtD
Brinzolamide—Diarrhoea—Paclitaxel—breast cancer	4.58e-05	0.000222	CcSEcCtD
Brinzolamide—Nervousness—Epirubicin—breast cancer	4.55e-05	0.000221	CcSEcCtD
Brinzolamide—Back pain—Epirubicin—breast cancer	4.53e-05	0.00022	CcSEcCtD
Brinzolamide—Feeling abnormal—Capecitabine—breast cancer	4.52e-05	0.00022	CcSEcCtD
Brinzolamide—Angiopathy—Doxorubicin—breast cancer	4.52e-05	0.000219	CcSEcCtD
Brinzolamide—Malaise—Methotrexate—breast cancer	4.51e-05	0.000219	CcSEcCtD
Brinzolamide—Muscle spasms—Epirubicin—breast cancer	4.5e-05	0.000219	CcSEcCtD
Brinzolamide—Immune system disorder—Doxorubicin—breast cancer	4.5e-05	0.000218	CcSEcCtD
Brinzolamide—Vertigo—Methotrexate—breast cancer	4.5e-05	0.000218	CcSEcCtD
Brinzolamide—Mediastinal disorder—Doxorubicin—breast cancer	4.49e-05	0.000218	CcSEcCtD
Brinzolamide—Arrhythmia—Doxorubicin—breast cancer	4.45e-05	0.000216	CcSEcCtD
Brinzolamide—Dizziness—Paclitaxel—breast cancer	4.42e-05	0.000215	CcSEcCtD
Brinzolamide—Vision blurred—Epirubicin—breast cancer	4.42e-05	0.000214	CcSEcCtD
Brinzolamide—Alopecia—Doxorubicin—breast cancer	4.4e-05	0.000214	CcSEcCtD
Brinzolamide—Cough—Methotrexate—breast cancer	4.37e-05	0.000212	CcSEcCtD
Brinzolamide—Mental disorder—Doxorubicin—breast cancer	4.36e-05	0.000212	CcSEcCtD
Brinzolamide—Urticaria—Capecitabine—breast cancer	4.36e-05	0.000212	CcSEcCtD
Brinzolamide—Ill-defined disorder—Epirubicin—breast cancer	4.35e-05	0.000211	CcSEcCtD
Brinzolamide—Malnutrition—Doxorubicin—breast cancer	4.33e-05	0.000211	CcSEcCtD
Brinzolamide—Erythema—Doxorubicin—breast cancer	4.33e-05	0.000211	CcSEcCtD
Brinzolamide—Agitation—Epirubicin—breast cancer	4.31e-05	0.000209	CcSEcCtD
Brinzolamide—Flatulence—Doxorubicin—breast cancer	4.27e-05	0.000207	CcSEcCtD
Brinzolamide—Myalgia—Methotrexate—breast cancer	4.26e-05	0.000207	CcSEcCtD
Brinzolamide—Arthralgia—Methotrexate—breast cancer	4.26e-05	0.000207	CcSEcCtD
Brinzolamide—Chest pain—Methotrexate—breast cancer	4.26e-05	0.000207	CcSEcCtD
Brinzolamide—Tension—Doxorubicin—breast cancer	4.25e-05	0.000207	CcSEcCtD
Brinzolamide—Vomiting—Paclitaxel—breast cancer	4.25e-05	0.000207	CcSEcCtD
Brinzolamide—Dysgeusia—Doxorubicin—breast cancer	4.25e-05	0.000206	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	4.23e-05	0.000206	CcSEcCtD
Brinzolamide—Malaise—Epirubicin—breast cancer	4.22e-05	0.000205	CcSEcCtD
Brinzolamide—Rash—Paclitaxel—breast cancer	4.22e-05	0.000205	CcSEcCtD
Brinzolamide—Dermatitis—Paclitaxel—breast cancer	4.21e-05	0.000205	CcSEcCtD
Brinzolamide—Discomfort—Methotrexate—breast cancer	4.21e-05	0.000205	CcSEcCtD
Brinzolamide—Nervousness—Doxorubicin—breast cancer	4.21e-05	0.000205	CcSEcCtD
Brinzolamide—Vertigo—Epirubicin—breast cancer	4.21e-05	0.000204	CcSEcCtD
Brinzolamide—Back pain—Doxorubicin—breast cancer	4.19e-05	0.000204	CcSEcCtD
Brinzolamide—Headache—Paclitaxel—breast cancer	4.19e-05	0.000204	CcSEcCtD
Brinzolamide—Hypersensitivity—Docetaxel—breast cancer	4.18e-05	0.000203	CcSEcCtD
Brinzolamide—Muscle spasms—Doxorubicin—breast cancer	4.17e-05	0.000202	CcSEcCtD
Brinzolamide—Palpitations—Epirubicin—breast cancer	4.14e-05	0.000201	CcSEcCtD
Brinzolamide—Cough—Epirubicin—breast cancer	4.09e-05	0.000199	CcSEcCtD
Brinzolamide—Vision blurred—Doxorubicin—breast cancer	4.09e-05	0.000198	CcSEcCtD
Brinzolamide—Asthenia—Docetaxel—breast cancer	4.07e-05	0.000198	CcSEcCtD
Brinzolamide—Infection—Methotrexate—breast cancer	4.06e-05	0.000197	CcSEcCtD
Brinzolamide—Hypertension—Epirubicin—breast cancer	4.04e-05	0.000196	CcSEcCtD
Brinzolamide—Hypersensitivity—Capecitabine—breast cancer	4.04e-05	0.000196	CcSEcCtD
Brinzolamide—Ill-defined disorder—Doxorubicin—breast cancer	4.02e-05	0.000195	CcSEcCtD
Brinzolamide—Pruritus—Docetaxel—breast cancer	4.01e-05	0.000195	CcSEcCtD
Brinzolamide—Nervous system disorder—Methotrexate—breast cancer	4.01e-05	0.000195	CcSEcCtD
Brinzolamide—Chest pain—Epirubicin—breast cancer	3.99e-05	0.000194	CcSEcCtD
Brinzolamide—Myalgia—Epirubicin—breast cancer	3.99e-05	0.000194	CcSEcCtD
Brinzolamide—Arthralgia—Epirubicin—breast cancer	3.99e-05	0.000194	CcSEcCtD
Brinzolamide—Agitation—Doxorubicin—breast cancer	3.98e-05	0.000194	CcSEcCtD
Brinzolamide—Nausea—Paclitaxel—breast cancer	3.97e-05	0.000193	CcSEcCtD
Brinzolamide—Skin disorder—Methotrexate—breast cancer	3.97e-05	0.000193	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	3.96e-05	0.000192	CcSEcCtD
Brinzolamide—Discomfort—Epirubicin—breast cancer	3.94e-05	0.000191	CcSEcCtD
Brinzolamide—Asthenia—Capecitabine—breast cancer	3.94e-05	0.000191	CcSEcCtD
Brinzolamide—Malaise—Doxorubicin—breast cancer	3.91e-05	0.00019	CcSEcCtD
Brinzolamide—Dry mouth—Epirubicin—breast cancer	3.9e-05	0.000189	CcSEcCtD
Brinzolamide—Vertigo—Doxorubicin—breast cancer	3.89e-05	0.000189	CcSEcCtD
Brinzolamide—Pruritus—Capecitabine—breast cancer	3.88e-05	0.000189	CcSEcCtD
Brinzolamide—Diarrhoea—Docetaxel—breast cancer	3.88e-05	0.000188	CcSEcCtD
Brinzolamide—Palpitations—Doxorubicin—breast cancer	3.83e-05	0.000186	CcSEcCtD
Brinzolamide—Hypotension—Methotrexate—breast cancer	3.82e-05	0.000185	CcSEcCtD
Brinzolamide—Infection—Epirubicin—breast cancer	3.8e-05	0.000185	CcSEcCtD
Brinzolamide—Cough—Doxorubicin—breast cancer	3.78e-05	0.000184	CcSEcCtD
Brinzolamide—Diarrhoea—Capecitabine—breast cancer	3.76e-05	0.000182	CcSEcCtD
Brinzolamide—Nervous system disorder—Epirubicin—breast cancer	3.75e-05	0.000182	CcSEcCtD
Brinzolamide—Dizziness—Docetaxel—breast cancer	3.75e-05	0.000182	CcSEcCtD
Brinzolamide—Hypertension—Doxorubicin—breast cancer	3.74e-05	0.000182	CcSEcCtD
Brinzolamide—Tachycardia—Epirubicin—breast cancer	3.73e-05	0.000181	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Methotrexate—breast cancer	3.72e-05	0.000181	CcSEcCtD
Brinzolamide—Skin disorder—Epirubicin—breast cancer	3.71e-05	0.00018	CcSEcCtD
Brinzolamide—Insomnia—Methotrexate—breast cancer	3.7e-05	0.00018	CcSEcCtD
Brinzolamide—Myalgia—Doxorubicin—breast cancer	3.69e-05	0.000179	CcSEcCtD
Brinzolamide—Chest pain—Doxorubicin—breast cancer	3.69e-05	0.000179	CcSEcCtD
Brinzolamide—Arthralgia—Doxorubicin—breast cancer	3.69e-05	0.000179	CcSEcCtD
Brinzolamide—Paraesthesia—Methotrexate—breast cancer	3.67e-05	0.000178	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	3.67e-05	0.000178	CcSEcCtD
Brinzolamide—Discomfort—Doxorubicin—breast cancer	3.65e-05	0.000177	CcSEcCtD
Brinzolamide—Dyspnoea—Methotrexate—breast cancer	3.64e-05	0.000177	CcSEcCtD
Brinzolamide—Somnolence—Methotrexate—breast cancer	3.63e-05	0.000176	CcSEcCtD
Brinzolamide—Dizziness—Capecitabine—breast cancer	3.63e-05	0.000176	CcSEcCtD
Brinzolamide—Dry mouth—Doxorubicin—breast cancer	3.61e-05	0.000175	CcSEcCtD
Brinzolamide—Vomiting—Docetaxel—breast cancer	3.6e-05	0.000175	CcSEcCtD
Brinzolamide—Dyspepsia—Methotrexate—breast cancer	3.6e-05	0.000175	CcSEcCtD
Brinzolamide—Rash—Docetaxel—breast cancer	3.57e-05	0.000174	CcSEcCtD
Brinzolamide—Hypotension—Epirubicin—breast cancer	3.57e-05	0.000174	CcSEcCtD
Brinzolamide—Dermatitis—Docetaxel—breast cancer	3.57e-05	0.000173	CcSEcCtD
Brinzolamide—Decreased appetite—Methotrexate—breast cancer	3.55e-05	0.000173	CcSEcCtD
Brinzolamide—Headache—Docetaxel—breast cancer	3.55e-05	0.000173	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Methotrexate—breast cancer	3.53e-05	0.000171	CcSEcCtD
Brinzolamide—Fatigue—Methotrexate—breast cancer	3.52e-05	0.000171	CcSEcCtD
Brinzolamide—Infection—Doxorubicin—breast cancer	3.51e-05	0.000171	CcSEcCtD
Brinzolamide—Pain—Methotrexate—breast cancer	3.49e-05	0.00017	CcSEcCtD
Brinzolamide—Vomiting—Capecitabine—breast cancer	3.49e-05	0.00017	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Epirubicin—breast cancer	3.48e-05	0.000169	CcSEcCtD
Brinzolamide—Nervous system disorder—Doxorubicin—breast cancer	3.47e-05	0.000169	CcSEcCtD
Brinzolamide—Rash—Capecitabine—breast cancer	3.46e-05	0.000168	CcSEcCtD
Brinzolamide—Insomnia—Epirubicin—breast cancer	3.46e-05	0.000168	CcSEcCtD
Brinzolamide—Dermatitis—Capecitabine—breast cancer	3.46e-05	0.000168	CcSEcCtD
Brinzolamide—Tachycardia—Doxorubicin—breast cancer	3.45e-05	0.000168	CcSEcCtD
Brinzolamide—Headache—Capecitabine—breast cancer	3.44e-05	0.000167	CcSEcCtD
Brinzolamide—Skin disorder—Doxorubicin—breast cancer	3.44e-05	0.000167	CcSEcCtD
Brinzolamide—Paraesthesia—Epirubicin—breast cancer	3.43e-05	0.000167	CcSEcCtD
Brinzolamide—Dyspnoea—Epirubicin—breast cancer	3.41e-05	0.000166	CcSEcCtD
Brinzolamide—Somnolence—Epirubicin—breast cancer	3.4e-05	0.000165	CcSEcCtD
Brinzolamide—Nausea—Docetaxel—breast cancer	3.37e-05	0.000164	CcSEcCtD
Brinzolamide—Feeling abnormal—Methotrexate—breast cancer	3.37e-05	0.000164	CcSEcCtD
Brinzolamide—Dyspepsia—Epirubicin—breast cancer	3.37e-05	0.000163	CcSEcCtD
Brinzolamide—Decreased appetite—Epirubicin—breast cancer	3.32e-05	0.000161	CcSEcCtD
Brinzolamide—Hypotension—Doxorubicin—breast cancer	3.31e-05	0.000161	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Epirubicin—breast cancer	3.3e-05	0.00016	CcSEcCtD
Brinzolamide—Fatigue—Epirubicin—breast cancer	3.3e-05	0.00016	CcSEcCtD
Brinzolamide—Pain—Epirubicin—breast cancer	3.27e-05	0.000159	CcSEcCtD
Brinzolamide—Nausea—Capecitabine—breast cancer	3.26e-05	0.000158	CcSEcCtD
Brinzolamide—Urticaria—Methotrexate—breast cancer	3.25e-05	0.000158	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Doxorubicin—breast cancer	3.22e-05	0.000157	CcSEcCtD
Brinzolamide—Insomnia—Doxorubicin—breast cancer	3.2e-05	0.000155	CcSEcCtD
Brinzolamide—Paraesthesia—Doxorubicin—breast cancer	3.18e-05	0.000154	CcSEcCtD
Brinzolamide—Dyspnoea—Doxorubicin—breast cancer	3.15e-05	0.000153	CcSEcCtD
Brinzolamide—Feeling abnormal—Epirubicin—breast cancer	3.15e-05	0.000153	CcSEcCtD
Brinzolamide—Somnolence—Doxorubicin—breast cancer	3.15e-05	0.000153	CcSEcCtD
Brinzolamide—Dyspepsia—Doxorubicin—breast cancer	3.11e-05	0.000151	CcSEcCtD
Brinzolamide—Decreased appetite—Doxorubicin—breast cancer	3.08e-05	0.000149	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Doxorubicin—breast cancer	3.05e-05	0.000148	CcSEcCtD
Brinzolamide—Fatigue—Doxorubicin—breast cancer	3.05e-05	0.000148	CcSEcCtD
Brinzolamide—Urticaria—Epirubicin—breast cancer	3.04e-05	0.000148	CcSEcCtD
Brinzolamide—Pain—Doxorubicin—breast cancer	3.03e-05	0.000147	CcSEcCtD
Brinzolamide—Hypersensitivity—Methotrexate—breast cancer	3.01e-05	0.000146	CcSEcCtD
Brinzolamide—Asthenia—Methotrexate—breast cancer	2.93e-05	0.000142	CcSEcCtD
Brinzolamide—Feeling abnormal—Doxorubicin—breast cancer	2.92e-05	0.000142	CcSEcCtD
Brinzolamide—Pruritus—Methotrexate—breast cancer	2.89e-05	0.00014	CcSEcCtD
Brinzolamide—Hypersensitivity—Epirubicin—breast cancer	2.82e-05	0.000137	CcSEcCtD
Brinzolamide—Urticaria—Doxorubicin—breast cancer	2.81e-05	0.000137	CcSEcCtD
Brinzolamide—Diarrhoea—Methotrexate—breast cancer	2.8e-05	0.000136	CcSEcCtD
Brinzolamide—Asthenia—Epirubicin—breast cancer	2.74e-05	0.000133	CcSEcCtD
Brinzolamide—Pruritus—Epirubicin—breast cancer	2.71e-05	0.000131	CcSEcCtD
Brinzolamide—Dizziness—Methotrexate—breast cancer	2.7e-05	0.000131	CcSEcCtD
Brinzolamide—Diarrhoea—Epirubicin—breast cancer	2.62e-05	0.000127	CcSEcCtD
Brinzolamide—Hypersensitivity—Doxorubicin—breast cancer	2.61e-05	0.000127	CcSEcCtD
Brinzolamide—Vomiting—Methotrexate—breast cancer	2.6e-05	0.000126	CcSEcCtD
Brinzolamide—Rash—Methotrexate—breast cancer	2.58e-05	0.000125	CcSEcCtD
Brinzolamide—Dermatitis—Methotrexate—breast cancer	2.57e-05	0.000125	CcSEcCtD
Brinzolamide—Headache—Methotrexate—breast cancer	2.56e-05	0.000124	CcSEcCtD
Brinzolamide—Asthenia—Doxorubicin—breast cancer	2.54e-05	0.000123	CcSEcCtD
Brinzolamide—Dizziness—Epirubicin—breast cancer	2.53e-05	0.000123	CcSEcCtD
Brinzolamide—Pruritus—Doxorubicin—breast cancer	2.5e-05	0.000122	CcSEcCtD
Brinzolamide—Vomiting—Epirubicin—breast cancer	2.43e-05	0.000118	CcSEcCtD
Brinzolamide—Nausea—Methotrexate—breast cancer	2.43e-05	0.000118	CcSEcCtD
Brinzolamide—Diarrhoea—Doxorubicin—breast cancer	2.42e-05	0.000118	CcSEcCtD
Brinzolamide—Rash—Epirubicin—breast cancer	2.41e-05	0.000117	CcSEcCtD
Brinzolamide—Dermatitis—Epirubicin—breast cancer	2.41e-05	0.000117	CcSEcCtD
Brinzolamide—Headache—Epirubicin—breast cancer	2.4e-05	0.000116	CcSEcCtD
Brinzolamide—Dizziness—Doxorubicin—breast cancer	2.34e-05	0.000114	CcSEcCtD
Brinzolamide—Nausea—Epirubicin—breast cancer	2.27e-05	0.00011	CcSEcCtD
Brinzolamide—Vomiting—Doxorubicin—breast cancer	2.25e-05	0.000109	CcSEcCtD
Brinzolamide—Rash—Doxorubicin—breast cancer	2.23e-05	0.000108	CcSEcCtD
Brinzolamide—Dermatitis—Doxorubicin—breast cancer	2.23e-05	0.000108	CcSEcCtD
Brinzolamide—Headache—Doxorubicin—breast cancer	2.22e-05	0.000108	CcSEcCtD
Brinzolamide—Nausea—Doxorubicin—breast cancer	2.1e-05	0.000102	CcSEcCtD
Brinzolamide—CA4—Metabolism—HMOX1—breast cancer	1.86e-05	0.000233	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—ITPR1—breast cancer	1.85e-05	0.000233	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—NQO1—breast cancer	1.83e-05	0.000229	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—SLC2A1—breast cancer	1.83e-05	0.000229	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—COMT—breast cancer	1.82e-05	0.000228	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—GSTP1—breast cancer	1.81e-05	0.000227	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—IL6—breast cancer	1.78e-05	0.000224	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—ABCB1—breast cancer	1.78e-05	0.000224	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—HMOX1—breast cancer	1.78e-05	0.000224	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CYP3A4—breast cancer	1.78e-05	0.000223	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—ITPR1—breast cancer	1.78e-05	0.000223	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—CAV1—breast cancer	1.77e-05	0.000222	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—TYMS—breast cancer	1.75e-05	0.00022	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CYP1B1—breast cancer	1.75e-05	0.00022	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PIK3CG—breast cancer	1.74e-05	0.000218	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PIK3CG—breast cancer	1.74e-05	0.000218	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—COMT—breast cancer	1.74e-05	0.000218	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—GSTP1—breast cancer	1.73e-05	0.000217	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PLA2G4A—breast cancer	1.73e-05	0.000217	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—NCOR1—breast cancer	1.73e-05	0.000217	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—GSTM1—breast cancer	1.73e-05	0.000217	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—CYP1B1—breast cancer	1.72e-05	0.000216	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—HSP90AA1—breast cancer	1.72e-05	0.000215	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—ABCB1—breast cancer	1.71e-05	0.000215	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—HMOX1—breast cancer	1.71e-05	0.000214	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—ITPR1—breast cancer	1.7e-05	0.000214	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—CYP1B1—breast cancer	1.7e-05	0.000213	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PIK3CD—breast cancer	1.68e-05	0.000211	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—TYMS—breast cancer	1.68e-05	0.000211	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—NCOA1—breast cancer	1.67e-05	0.00021	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PLA2G4A—breast cancer	1.66e-05	0.000208	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—ALB—breast cancer	1.66e-05	0.000208	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—NCOR1—breast cancer	1.66e-05	0.000208	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—GSTM1—breast cancer	1.66e-05	0.000208	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—GPX1—breast cancer	1.66e-05	0.000208	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—STK11—breast cancer	1.65e-05	0.000207	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CYP19A1—breast cancer	1.65e-05	0.000207	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—NCOA1—breast cancer	1.64e-05	0.000206	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—CYP1A1—breast cancer	1.64e-05	0.000206	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—ABCB1—breast cancer	1.64e-05	0.000206	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PIK3CD—breast cancer	1.64e-05	0.000206	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PIK3CD—breast cancer	1.64e-05	0.000206	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—ERCC2—breast cancer	1.63e-05	0.000204	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—CYP19A1—breast cancer	1.62e-05	0.000203	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—ALB—breast cancer	1.62e-05	0.000203	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—ALB—breast cancer	1.62e-05	0.000203	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PIK3CG—breast cancer	1.61e-05	0.000202	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—TYMS—breast cancer	1.61e-05	0.000202	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—CYP19A1—breast cancer	1.6e-05	0.0002	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PLA2G4A—breast cancer	1.59e-05	0.0002	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—NCOR1—breast cancer	1.59e-05	0.0002	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—GSTM1—breast cancer	1.59e-05	0.0002	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—GPX1—breast cancer	1.59e-05	0.0002	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—NOS3—breast cancer	1.59e-05	0.000199	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—CYP1A1—breast cancer	1.57e-05	0.000198	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—ERCC2—breast cancer	1.56e-05	0.000196	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—NOS3—breast cancer	1.55e-05	0.000194	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—NOS3—breast cancer	1.55e-05	0.000194	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—MTHFR—breast cancer	1.53e-05	0.000192	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PIK3CD—breast cancer	1.53e-05	0.000192	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PIK3CD—breast cancer	1.53e-05	0.000192	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—COMT—breast cancer	1.53e-05	0.000192	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—GPX1—breast cancer	1.52e-05	0.000191	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—GSTP1—breast cancer	1.52e-05	0.000191	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—ALB—breast cancer	1.51e-05	0.00019	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—ALB—breast cancer	1.51e-05	0.00019	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—CYP1A1—breast cancer	1.51e-05	0.000189	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—COMT—breast cancer	1.51e-05	0.000189	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—HMOX1—breast cancer	1.5e-05	0.000188	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—GSTP1—breast cancer	1.5e-05	0.000188	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—ITPR1—breast cancer	1.5e-05	0.000188	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—ERCC2—breast cancer	1.5e-05	0.000188	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—COMT—breast cancer	1.49e-05	0.000186	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—GSTP1—breast cancer	1.48e-05	0.000186	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—MTHFR—breast cancer	1.47e-05	0.000184	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PIK3CB—breast cancer	1.47e-05	0.000184	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PTGS2—breast cancer	1.45e-05	0.000182	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—NOS3—breast cancer	1.45e-05	0.000181	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—NOS3—breast cancer	1.45e-05	0.000181	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—ABCB1—breast cancer	1.44e-05	0.000181	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PIK3CB—breast cancer	1.43e-05	0.000179	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PIK3CB—breast cancer	1.43e-05	0.000179	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PIK3CD—breast cancer	1.42e-05	0.000178	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—TYMS—breast cancer	1.42e-05	0.000178	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PTGS2—breast cancer	1.42e-05	0.000178	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PTGS2—breast cancer	1.42e-05	0.000178	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—CAV1—breast cancer	1.41e-05	0.000177	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—MTHFR—breast cancer	1.41e-05	0.000177	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—GSTM1—breast cancer	1.4e-05	0.000176	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PLA2G4A—breast cancer	1.4e-05	0.000176	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—NCOR1—breast cancer	1.4e-05	0.000176	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—ALB—breast cancer	1.4e-05	0.000176	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—GSTM1—breast cancer	1.38e-05	0.000173	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—GSTM1—breast cancer	1.36e-05	0.00017	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—CAV1—breast cancer	1.35e-05	0.00017	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—GPX1—breast cancer	1.34e-05	0.000168	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—NOS3—breast cancer	1.34e-05	0.000168	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PIK3CB—breast cancer	1.33e-05	0.000167	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PIK3CB—breast cancer	1.33e-05	0.000167	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CYP1A1—breast cancer	1.33e-05	0.000166	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PTGS2—breast cancer	1.32e-05	0.000166	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PTGS2—breast cancer	1.32e-05	0.000166	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—ERCC2—breast cancer	1.32e-05	0.000165	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—CYP1A1—breast cancer	1.31e-05	0.000164	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—CAV1—breast cancer	1.3e-05	0.000163	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—CYP1A1—breast cancer	1.29e-05	0.000162	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PIK3CG—breast cancer	1.29e-05	0.000161	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PTEN—breast cancer	1.27e-05	0.000159	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—MTHFR—breast cancer	1.24e-05	0.000155	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PIK3CB—breast cancer	1.24e-05	0.000155	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PTEN—breast cancer	1.23e-05	0.000155	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PTEN—breast cancer	1.23e-05	0.000155	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PIK3CG—breast cancer	1.23e-05	0.000155	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PTGS2—breast cancer	1.22e-05	0.000154	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PIK3CG—breast cancer	1.18e-05	0.000148	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PTEN—breast cancer	1.15e-05	0.000145	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PTEN—breast cancer	1.15e-05	0.000145	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CAV1—breast cancer	1.14e-05	0.000143	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PIK3CD—breast cancer	1.13e-05	0.000142	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—ALB—breast cancer	1.12e-05	0.00014	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PIK3CD—breast cancer	1.08e-05	0.000136	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—ALB—breast cancer	1.07e-05	0.000134	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PTEN—breast cancer	1.07e-05	0.000134	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—NOS3—breast cancer	1.07e-05	0.000134	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—SYNJ2—breast cancer	1.05e-05	0.000132	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PIK3CG—breast cancer	1.04e-05	0.00013	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PIK3CD—breast cancer	1.04e-05	0.00013	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—ALB—breast cancer	1.03e-05	0.000129	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—NOS3—breast cancer	1.02e-05	0.000128	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PIK3CB—breast cancer	9.85e-06	0.000124	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—NOS3—breast cancer	9.81e-06	0.000123	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—NDUFS3—breast cancer	9.77e-06	0.000123	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PTGS2—breast cancer	9.76e-06	0.000123	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PIK3CB—breast cancer	9.45e-06	0.000119	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PTGS2—breast cancer	9.36e-06	0.000117	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CHST9—breast cancer	9.18e-06	0.000115	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PIK3CD—breast cancer	9.14e-06	0.000115	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PIK3CB—breast cancer	9.06e-06	0.000114	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—ALB—breast cancer	9.02e-06	0.000113	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PTGS2—breast cancer	8.97e-06	0.000113	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PIK3CA—breast cancer	8.94e-06	0.000112	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PIK3CA—breast cancer	8.71e-06	0.000109	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PIK3CA—breast cancer	8.71e-06	0.000109	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—COX11—breast cancer	8.71e-06	0.000109	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—NOS3—breast cancer	8.63e-06	0.000108	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PTEN—breast cancer	8.52e-06	0.000107	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PTEN—breast cancer	8.16e-06	0.000102	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PIK3CA—breast cancer	8.13e-06	0.000102	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PIK3CA—breast cancer	8.13e-06	0.000102	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CDA—breast cancer	7.96e-06	9.99e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—SHMT1—breast cancer	7.96e-06	9.99e-05	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PIK3CB—breast cancer	7.96e-06	9.99e-05	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PTGS2—breast cancer	7.89e-06	9.9e-05	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PTEN—breast cancer	7.83e-06	9.82e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—SLC2A5—breast cancer	7.66e-06	9.62e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—SLCO1B1—breast cancer	7.66e-06	9.62e-05	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PIK3CA—breast cancer	7.53e-06	9.45e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—APRT—breast cancer	7.4e-06	9.29e-05	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—AKT1—breast cancer	7.3e-06	9.16e-05	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—AKT1—breast cancer	7.12e-06	8.93e-05	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—AKT1—breast cancer	7.12e-06	8.93e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ESRRA—breast cancer	6.96e-06	8.73e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ANGPTL4—breast cancer	6.96e-06	8.73e-05	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PTEN—breast cancer	6.88e-06	8.63e-05	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—AKT1—breast cancer	6.64e-06	8.33e-05	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—AKT1—breast cancer	6.64e-06	8.33e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—HADHB—breast cancer	6.6e-06	8.28e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GPI—breast cancer	6.6e-06	8.28e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ALDH1A1—breast cancer	6.29e-06	7.9e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ALDH7A1—breast cancer	6.29e-06	7.9e-05	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—AKT1—breast cancer	6.15e-06	7.72e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PHGDH—breast cancer	6.03e-06	7.57e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ADSL—breast cancer	6.03e-06	7.57e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—UMPS—breast cancer	6.03e-06	7.57e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—FHL2—breast cancer	6.03e-06	7.57e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—NME1—breast cancer	6.03e-06	7.57e-05	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PIK3CA—breast cancer	6.01e-06	7.54e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—BRIP1—breast cancer	5.92e-06	7.43e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—HPSE—breast cancer	5.92e-06	7.43e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—LDHB—breast cancer	5.92e-06	7.43e-05	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PIK3CA—breast cancer	5.76e-06	7.23e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GSTA3—breast cancer	5.61e-06	7.04e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—HMMR—breast cancer	5.61e-06	7.04e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ABCC1—breast cancer	5.61e-06	7.04e-05	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PIK3CA—breast cancer	5.52e-06	6.93e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PPARGC1B—breast cancer	5.43e-06	6.82e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GSTA4—breast cancer	5.13e-06	6.44e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CA9—breast cancer	5.13e-06	6.44e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GSTA2—breast cancer	5e-06	6.27e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GPX2—breast cancer	5e-06	6.27e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GPX4—breast cancer	4.94e-06	6.2e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—SULT1A1—breast cancer	4.94e-06	6.2e-05	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—AKT1—breast cancer	4.91e-06	6.16e-05	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PIK3CA—breast cancer	4.85e-06	6.09e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—IDH1—breast cancer	4.82e-06	6.05e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GSTA1—breast cancer	4.82e-06	6.05e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—NAT2—breast cancer	4.77e-06	5.99e-05	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—AKT1—breast cancer	4.7e-06	5.9e-05	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—AKT1—breast cancer	4.51e-06	5.66e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—DPYD—breast cancer	4.18e-06	5.25e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—MED12—breast cancer	4.18e-06	5.25e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ALDOA—breast cancer	4.12e-06	5.17e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—NCOA3—breast cancer	4e-06	5.02e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—SLC2A2—breast cancer	3.97e-06	4.98e-05	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—AKT1—breast cancer	3.97e-06	4.98e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—MTR—breast cancer	3.89e-06	4.88e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ABCG2—breast cancer	3.89e-06	4.88e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CPT1A—breast cancer	3.89e-06	4.88e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—HPGDS—breast cancer	3.81e-06	4.78e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—HBA1—breast cancer	3.79e-06	4.75e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ACHE—breast cancer	3.7e-06	4.64e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GSTT1—breast cancer	3.7e-06	4.64e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CYP17A1—breast cancer	3.5e-06	4.39e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ENO1—breast cancer	3.47e-06	4.35e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PTGS1—breast cancer	3.47e-06	4.35e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CYP2D6—breast cancer	3.4e-06	4.26e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—NCOA2—breast cancer	3.34e-06	4.19e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—FASN—breast cancer	3.24e-06	4.06e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—BCHE—breast cancer	3.22e-06	4.04e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—SLC5A5—breast cancer	3.18e-06	3.99e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—NQO1—breast cancer	3.07e-06	3.86e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—SLC2A1—breast cancer	3.07e-06	3.86e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CYP1B1—breast cancer	2.95e-06	3.7e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—HSP90AA1—breast cancer	2.89e-06	3.63e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—NCOA1—breast cancer	2.81e-06	3.53e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—STK11—breast cancer	2.77e-06	3.48e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CYP19A1—breast cancer	2.77e-06	3.48e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—COMT—breast cancer	2.58e-06	3.23e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GSTP1—breast cancer	2.56e-06	3.22e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—HMOX1—breast cancer	2.53e-06	3.17e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ITPR1—breast cancer	2.52e-06	3.17e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ABCB1—breast cancer	2.43e-06	3.05e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—TYMS—breast cancer	2.38e-06	2.99e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PLA2G4A—breast cancer	2.36e-06	2.96e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GSTM1—breast cancer	2.36e-06	2.96e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—NCOR1—breast cancer	2.36e-06	2.96e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GPX1—breast cancer	2.26e-06	2.83e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CYP1A1—breast cancer	2.23e-06	2.8e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ERCC2—breast cancer	2.22e-06	2.78e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—MTHFR—breast cancer	2.08e-06	2.61e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CAV1—breast cancer	1.92e-06	2.41e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PIK3CG—breast cancer	1.75e-06	2.19e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PIK3CD—breast cancer	1.54e-06	1.93e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ALB—breast cancer	1.52e-06	1.9e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—NOS3—breast cancer	1.45e-06	1.82e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PIK3CB—breast cancer	1.34e-06	1.68e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PTGS2—breast cancer	1.33e-06	1.67e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PTEN—breast cancer	1.16e-06	1.45e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PIK3CA—breast cancer	8.17e-07	1.03e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—AKT1—breast cancer	6.68e-07	8.38e-06	CbGpPWpGaD
